Clinical Trials Directory

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma

To evaluate the role of allogeneic hematopoietic cell transplantation in the treatment of NHL.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • procedure : ablative allogeneic hematopoietic cell transplantation

Phase: Phase 2


Ages Eligible For Study:

18 Years - 61 Years

Inclusion Criteria

Morphologically confirmed relapsed non-Hodgkin's lymphoma Age: >18 and <61 years of age Signed informed consent

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
Not Recruiting

Footer Links: